Salient Pharma ApS — Credit Rating and Financial Key Figures

CVR number: 36900709
Naverland 22, 2600 Glostrup
us@salientpharma.com
tel: 42806300
www.salientpharma.com

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit- 484.92- 261.31- 125.51- 233.31- 124.37
Employee benefit expenses- 402.94
EBIT- 887.87- 261.31- 125.51- 233.31- 124.37
Other financial expenses-13.73-39.95-62.65-71.62-77.81
Pre-tax profit- 901.59- 301.26- 188.16- 304.93- 202.18
Net earnings- 901.59- 301.26- 188.16- 304.93- 202.18

Assets (kDKK)

2020
2021
2022
2023
2024
Intangible assets total
Tangible assets total
Investments total
Long term receivables total
Finished products/goods12.1611.46
Inventories total12.1611.46
Current trade debtors3.46
Current other receivables32.7417.8117.5912.281.08
Short term receivables total32.7417.8117.5915.731.08
Cash and bank deposits12.4824.9328.964.8917.94
Cash and cash equivalents12.4824.9328.964.8917.94
Balance sheet total (assets)45.2254.9058.0120.6219.02

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital57.1257.1257.12182.66419.92
Retained earnings352.53- 549.06- 850.32-1 038.48-1 343.40
Profit of the financial year- 901.59- 301.26- 188.16- 304.93- 202.18
Shareholders equity total- 491.95- 793.20- 981.37-1 160.74-1 125.66
Non-current liabilities total
Advances received3.41
Current trade creditors113.90162.55147.02217.62100.44
Current owed to participating341.67680.09892.36963.741 040.84
Other non-interest bearing current liabilities81.605.46
Current liabilities total537.16848.101 039.371 181.371 144.69
Balance sheet total (liabilities)45.2254.9058.0120.6219.02
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.